|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD
628.32 Million
|
|
CAGR (2025-2030)
|
8.45%
|
|
Fastest Growing Segment
|
Infectious
Disease
|
|
Largest Market
|
South India
|
|
Market Size (2030)
|
USD 1,024.57 Million
|
Market Overview
India Point of Care Diagnostics Market
was valued at USD 628.32 Million in 2024 and is expected to reach USD 1,024.57 Million
by 2030 with a CAGR of 8.45% during the forecast period.
The India Point of
Care (POC) Diagnostics Market is experiencing significant growth, driven by a
combination of rising healthcare demands and technological advancements. The
increasing prevalence of chronic diseases such as diabetes and cardiovascular
conditions, along with the growing burden of infectious diseases, is fueling
the demand for quick and efficient diagnostic solutions.
Additionally, the
expanding healthcare infrastructure in rural areas, supported by government
initiatives like Ayushman Bharat, is improving access to POC diagnostics.
Technological innovations, such as mobile health integration and portable
diagnostic devices, are enhancing the accuracy and convenience of these tests,
making them more accessible to both urban and rural populations.
However, challenges such as the high
cost of advanced POC devices, regulatory hurdles, and limited reimbursement
policies in certain regions of India still pose barriers to market growth.
Moreover, the lack of widespread awareness about POC testing in rural areas and
concerns over the quality of some low-cost devices further complicate market
expansion. Despite these challenges, the sector's potential is bolstered by the
increasing health-consciousness of the Indian population, driving both demand
and adoption of POC diagnostic technologies.
Key Market Drivers
Rising
Prevalence of Chronic Diseases
India is facing a sharp rise in chronic diseases, which is driving the growth of the Point of Care (POC) diagnostics market. Conditions such as hypertension, diabetes, and cardiovascular diseases are becoming more common, especially in urban areas where poor diet, lack of exercise, and stress are widespread.
Recent data shows that 41.73% of adults in India suffer from at least one chronic condition. Hypertension affects 26.82% of the population, while 12.24% live with diabetes. The Indian Council of Medical Research (ICMR) projects that the number of diabetic patients will exceed 134 million by 2045, making India home to the second-largest diabetic population globally. Cardiovascular diseases are also a growing concern, with the Indian Heart Association estimating they will account for 60% of all deaths in the country by 2025.
This growing burden highlights the urgent need for accessible and timely diagnostic solutions. POC diagnostics allow early detection and continuous monitoring, supporting better disease management and reducing strain on healthcare systems, especially in areas with limited resources. The demand for cost-effective and quick testing solutions is expected to rise further as chronic conditions continue to increase..
Growing
Aging Population
India’s expanding elderly population is another major factor driving the POC diagnostics market. With longer life expectancy and an increasing proportion of people aged 60 and above, the need for healthcare solutions tailored to older adults is growing. Elderly individuals are more vulnerable to chronic conditions and require regular monitoring and convenient access to diagnostic tools.
The United Nations Population Fund (UNFPA) reported that in 2021, 10.1% of India’s population was aged 60 or above. This share is projected to reach 19.5% by 2050, nearly tripling the number of elderly individuals. Data from the National Sample Survey Organization (NSSO) shows that more than 70% of older adults in India live with at least one chronic disease.
Point of Care diagnostics provide practical solutions for this demographic by offering fast, reliable, and affordable testing. Devices such as blood glucose meters, cholesterol monitors, and blood pressure machines enable better disease management at home, in rural areas, and in long-term care facilities. These technologies reduce hospital visits and improve quality of care for elderly patients.
With the elderly population growing rapidly, demand for POC diagnostics will continue to rise, making them essential to managing chronic diseases and meeting the healthcare needs of aging communities in India.
Download Free Sample Report
Key Market Challenges
Limited
Awareness and Education
Limited awareness and education about Point of Care
(POC) diagnostics remain significant challenges to the widespread adoption of
these technologies in India. While urban areas have seen growing awareness of
the benefits and convenience offered by POC diagnostics, rural and remote
regions lag behind in understanding how these devices can improve healthcare
outcomes. Many healthcare professionals in smaller clinics, particularly in
underserved areas, may not be familiar with the latest advancements in POC
technologies or may lack proper training on how to effectively use these
devices. This gap in knowledge creates a barrier to integrating POC diagnostics
into daily healthcare practices.
Additionally, patients themselves may not fully
understand the importance of rapid, in-situ testing for early disease detection
and management, leading to hesitancy in utilizing POC services. This lack of
awareness often results in underutilization of POC diagnostics, especially in
rural regions where access to advanced healthcare facilities is limited.
Increasing education and awareness about the potential benefits and proper
usage of POC devices, both for healthcare professionals and patients, is essential
to boost adoption and ensure that these technologies are fully leveraged to
improve healthcare accessibility and outcomes across India.
Key Market Trends
Technological
Advancement
Technological innovation is reshaping the Point of Care (POC) diagnostics market in India by making devices faster, more accurate, and portable. The diagnostics sector, with POC diagnostics playing a growing role in this expansion.
One of the most important advancements is the integration of digital and mobile technologies. Many POC devices can now connect with smartphones, tablets, and cloud platforms, enabling real-time data transfer and remote monitoring by medical professionals. This is especially beneficial for Mobile Health Units (MHUs) in rural India, which use connected devices such as portable ECG machines and glucometers for managing chronic conditions. The Technology Development Board of India has supported the development of indigenous IoT-enabled, AI-powered blood testing devices, underlining the importance of this trend.
Miniaturization is another key area of progress. Modern POC devices are smaller, easier to use, and require minimal training, expanding their accessibility across both rural and urban settings. Handheld glucose meters and portable ECG machines allow patients to perform tests at home or in outpatient clinics without reliance on full laboratory setups.
Advancements in biosensors and biomarker technologies have further improved the sensitivity and accuracy of POC devices. These tools now enable earlier detection of conditions such as diabetes, cardiovascular disease, cancer, and infectious illnesses with minimal sample volumes like blood, urine, or saliva. Technologies such as microfluidics and nanotechnology are also enhancing device capabilities, allowing multiple tests such as ELISA and PCR to be conducted quickly and precisely on a single platform.
Together, these innovations are driving broader adoption of POC diagnostics across healthcare systems, supporting improved disease monitoring and management in both urban and underserved regions.
Segmental Insights
Product
Insights
Based on Product, Infectious Disease emerged as the fastest growing segment in the India Point of Care Diagnostics
Market in 2024. This is due to a combination of factors, particularly the
rising incidence of infectious diseases and the increasing demand for rapid,
on-site diagnostic solutions. Infectious diseases such as tuberculosis,
malaria, hepatitis, dengue, and COVID-19 remain prevalent across India, with
significant outbreaks occurring periodically. The urgency of diagnosing these
diseases quickly to ensure timely treatment and prevent further transmission
has highlighted the need for POC diagnostic tools. These devices allow
healthcare providers to quickly detect infections in a variety of settings,
including rural and remote areas where traditional laboratory services may not
be readily available.
The COVID-19 pandemic further accelerated the growth
of the Infectious Disease segment, as POC testing became a critical tool for
mass testing, monitoring, and controlling the spread of the virus. As a result,
there has been an increased focus on the development and adoption of portable,
user-friendly diagnostic devices capable of providing results in a matter of
minutes. Beyond COVID-19, the ongoing concerns over diseases like tuberculosis,
HIV, and vector-borne diseases such as dengue and malaria are driving demand
for faster and more efficient diagnostic solutions.
End
Use Insights
Based on End Use, Home emerged as
the fastest growing segment in the India Point of Care Diagnostics Market
during the forecast period. due to a combination of factors that reflect the
changing healthcare dynamics in the country. The increasing preference for
at-home healthcare solutions, driven by convenience, cost-effectiveness, and
the desire for timely results, has significantly contributed to the rise of
home care diagnostics. With more people seeking to monitor their health
independently, especially for chronic conditions such as diabetes,
hypertension, and heart disease, home diagnostic tools have become an essential
part of personal healthcare management.
Advancements in technology, particularly the
development of user-friendly devices like blood glucose meters, home pregnancy
tests, cholesterol monitors, and pulse oximeters, have made it easier for
individuals to perform tests without requiring professional assistance. These
devices are designed to be simple, accurate, and accessible, empowering
patients to take control of their health. For instance, continuous glucose
monitoring systems, which were once primarily used in hospitals, are now
available for home use, allowing diabetic patients to track their blood sugar
levels regularly.
Download Free Sample Report
Regional Insights
Based on Region, South India have
emerged as the dominating region in the India Point of Care Diagnostics Market
in 2024. due to a combination of factors that reflect the changing healthcare
dynamics in the country. South
India is dominating the Point of Care (POC) diagnostics market due to a
combination of factors, including its advanced healthcare infrastructure, high
urbanization, and significant investments in healthcare technology.
The region
is home to some of the country’s leading cities, such as Bengaluru, Chennai,
Hyderabad, and Kochi, which are known for their thriving healthcare sectors.
These cities have well-established healthcare facilities, including hospitals,
clinics, and diagnostic centers, that increasingly adopt POC diagnostic
solutions due to their efficiency and convenience. Additionally, South India
has a large concentration of healthcare professionals and institutions focusing
on research and development in medical technologies, which supports the
widespread adoption of innovative POC devices.
Another driving factor is the region's growing middle
class, which has led to increased healthcare spending and a higher demand for
quality diagnostic services. South India's strong education system, along with
its large pool of skilled professionals in medical technology, further promotes
the adoption of POC diagnostics. The region's focus on preventive healthcare,
coupled with increasing awareness of chronic diseases like diabetes,
cardiovascular issues, and infectious diseases, has created a fertile ground
for the growth of the POC diagnostics market.
Recent Development
- In September 2025, the Punjab government has introduced India’s first AI-enabled screening program for early detection of breast cancer, cervical cancer, and refractive errors, to advance preventive healthcare. Implemented in collaboration with the non-profit venture ACT Grants, the initiative is deploying portable, radiation-free, AI-powered devices across eight districts. Key technologies include Thermalytix by Niramai for breast cancer screening, Smart Scope by Periwinkle for cervical cancer screening, and a portable autorefractometer by Forus Health for vision impairment assessment. A launch event featured live demonstrations of all three systems.
- In August 2025, the Technology Development Board (TDB) of the Department of Science and Technology signed an agreement with Primary Healthtech Pvt. Ltd., New Delhi, to fund the development of an IoT-enabled, point-of-care blood-testing device. Powered by advanced AI/ML algorithms, the platform aims to provide affordable, accessible diagnostics for primary healthcare settings across India.
- In June 2024, India’s
innovative tuberculosis (TB) diagnostic technology received acclaim at the 2024
World Health Assembly for its rapid, accurate point-of-care testing. The
technology allows faster TB detection, crucial for global health efforts.
Recognized for its potential in resource-limited areas, it supports India’s
goal to eliminate TB by 2030.
- In May 2024, Cipla has increased its investment in
point-of-care testing company Achira Labs to enhance the development of
advanced diagnostic solutions. The partnership aims to accelerate the
availability of innovative, rapid diagnostic tests, strengthening Cipla's presence
in the healthcare technology sector and expanding access to affordable
healthcare solutions.
- In April 2024, Roche Diagnostics India’s
launch of a heart failure test specifically for diabetics as a point-of-care
(POC) device marks a significant step in advancing personalized healthcare.
This test is designed to provide rapid, on-site diagnostics for heart failure
in diabetic patients, a group that is at a higher risk of cardiovascular
diseases due to the long-term effects of diabetes on the heart and blood
vessels.
- In October 2023, Serum Institute of
India and Mylab have launched a new tuberculosis (TB) diagnostic kit for
detecting latent TB infections. This innovative kit provides a quicker, more
accessible method for identifying latent TB, which can help in early
intervention and prevent the progression to active TB, enhancing public health
efforts.
Key Market Players
- Roche
Products (India) Pvt. Ltd.
- Qiagen
India Pvt Ltd.
- Danaher
Corporation
- Becton
Dickinson Private Limited
- BioMérieux
- Siemens
Healthcare Private Limited
- Abbott
India Ltd
- Trividia
Health, Inc.
- Spectra
Medical India Pvt Ltd
- AccuBioTech
Co., Ltd.
|
By Product
|
By End Use
|
By Region
|
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Others
|
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratory
|
- East India
- West India
- North India
- South India
|
Report Scope
In this report, the India Point of Care Diagnostics
Market has been segmented into the following categories, in addition to the
industry trends which have also been detailed below:
- India Point of Care
Diagnostics Market, By
Product:
o Glucose Testing
o Hb1Ac Testing
o Coagulation Testing
o Fertility/Pregnancy
o Infectious Disease
o Cardiac Markers
o Thyroid Stimulating Hormone
o Hematology
o Primary Care Systems
o Others
- India Point of Care
Diagnostics Market, By
End Use:
o Clinics
o Hospitals
o Home
o Assisted Living Healthcare Facilities
o Laboratory
- India Point of Care
Diagnostics Market, By Region:
o East India
o West India
o North India
o South India
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present in the India Point of Care Diagnostics Market.
Available Customizations:
India Point of Care Diagnostics Market report with
the given market data, Tech Sci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
India Point of Care Diagnostics Market is an
upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]